1. Home
  2. SKY vs MIRM Comparison

SKY vs MIRM Comparison

Compare SKY & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SKY

Skyline Champion Corporation

HOLD

Current Price

$86.93

Market Cap

4.7B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$100.61

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKY
MIRM
Founded
2010
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SKY
MIRM
Price
$86.93
$100.61
Analyst Decision
Buy
Strong Buy
Analyst Count
2
11
Target Price
$101.00
$102.64
AVG Volume (30 Days)
906.1K
805.8K
Earning Date
02-03-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
32.12
N/A
EPS
3.74
N/A
Revenue
$2,636,228,000.00
$471,794,000.00
Revenue This Year
$7.67
$55.91
Revenue Next Year
$4.67
$23.97
P/E Ratio
$22.33
N/A
Revenue Growth
8.67
53.66
52 Week Low
$59.44
$36.88
52 Week High
$110.00
$105.74

Technical Indicators

Market Signals
Indicator
SKY
MIRM
Relative Strength Index (RSI) 51.75 64.10
Support Level $74.62 $97.49
Resistance Level $87.70 $105.74
Average True Range (ATR) 4.31 3.93
MACD -0.49 -0.55
Stochastic Oscillator 55.14 66.23

Price Performance

Historical Comparison
SKY
MIRM

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: